Ligands of second generation platinum analogs decrease both platinum-induced DNA cross-linking and its ability to interact with 1-β-D-arabinofuranosyl cytosine to potentiate cytotoxic efficacy-Reference-Cited by-同舟云学术

Ligands of second generation platinum analogs decrease both platinum-induced DNA cross-linking and its ability to interact with 1-β-D-arabinofuranosyl cytosine to potentiate cytotoxic efficacy

Published:1986-11 Issue:2 Volume:60 Page:159-169
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Drewinko B.,Yang L.Y.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference53 articles.

1. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-β-D-arabinofuranosylcytosine;Bergerat;Cancer Res.,1981

2. The lethal activity of platinum compounds in combination with pyrimidine derivatives;Drewinko,1980

3. The synergistic lethal interaction of cis-diamminedichloro- platinum and natural nucleosides is related to increased DNA cross-links;Drewinko;Chem.-Biol. Interact.,1985

4. Kinetics and mechanism of the arabinosyl cytosine-induced potentiation of cis-diammine-dichloroplatinum(II) cytotoxicity;Vadi;Cancer Res.,1986

5. ‘Platinum-pyrimidine blues’ and related complexes: A new class of potent antitumor agents;Davidson;Cancer Chemother., Rep.,1975

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of DNA/Protein interactions and cytotoxic studies of copper(II) complexes incorporated with N, N donor ligands and terpyridine ligand;International Journal of Biological Macromolecules;2017-02

2. DNA interaction and cytotoxic activity of copper complex based on tridentate hydrazone derived ligand and nitrogen donor heterocycle;Inorganic Chemistry Communications;2016-05

3. DNA/protein interaction and cytotoxic activity of imidazole terpyridine derived Cu(ii)/Zn(ii) metal complexes;Dalton Transactions;2014-07-03

4. Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction;European Journal of Cancer;1995-01